Advertisement
<< Back To Article
Activists Call for Earlier Access to Hep C Treatments

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

6 Comments

paul taylor

Were the activists able to secure any promises from the drug companies ? I have cirrhosis now and need access as soon as poss.Who were the activists ? Could do with speaking with someone.

July 3, 2011

paul taylor

Its great to see people having a voice over this matter-which for some is literally life or death. So the activits called for earlier access to treatments. The article is incomplete as there is no mention of a response from anywhere, or even a promise. Who are the activists I could do with a chat with someone. I have cirrhosis now and time is of the essence.Anyone out there-please make contact. Thanks

July 3, 2011

Tim Horn, hepmag.com

Rodney - Yes, it is hoped that the combination of two "direct acting antivirals" such as a protease inhibitor and an NS5A polymerase inhibitor will not only boost HCV cure rates, but potentially do away with the need for interferon treatment and its many side effects. Expect to see such clinical trials in the future.

June 20, 2011 New York, NY

Tim Horn, hepmag.com

Lisa - All of the new meds, including Victrelis, Incivek and the antivirals in development, should work better against genotype 1a than interferon and ribavirin alone. They should also work well in people with IL-28B TT, given that this gene only appears to affect responses to interferon therapy. Good news all around.

June 20, 2011 New York, NY

rodney wooley

wouldn't it the treatment be more effective with both protease andpolymase inhibtors together?

June 20, 2011 jasper,tx

Lisa

Can you tell me what percent the new meds will work on a geno 1a and TT? With advanced cirrhosis viral 1 mill 500 non an never drinker or drugs Or even if the med is avaiable to a person as such. Lisa

June 19, 2011 Big pine key

Advertisement

Hot topics


Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.